Healthcare Sector
Market Tracker
Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.
Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.
Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.
| Expires | Type | Strike | OI | Change | Percent |
|---|---|---|---|---|---|
| 01/15/2027 | PUT | $340.00 | 881 | +549 | +165.36% |
| 05/22/2026 | PUT | $325.00 | 251 | +251 | |
| 05/29/2026 | PUT | $325.00 | 251 | +251 | |
| 05/22/2026 | PUT | $370.00 | 250 | +250 | |
| 05/29/2026 | PUT | $370.00 | 250 | +250 | |
| 01/15/2027 | CALL | $540.00 | 272 | +217 | +394.55% |
| 07/17/2026 | CALL | $520.00 | 31 | -6 | -16.22% |
| 12/18/2026 | CALL | $700.00 | 417 | -10 | -2.34% |
| 01/15/2027 | CALL | $700.00 | 428 | -11 | -2.51% |
| 12/18/2026 | CALL | $740.00 | 168 | -12 | -6.67% |
| 01/15/2027 | CALL | $740.00 | 128 | -12 | -8.57% |
| 06/18/2026 | CALL | $500.00 | 787 | -14 | -1.75% |
Contracts with largest changes in open interest from the previous trading day to the current/most recent.
| Name | Pct Held | Shares | Total |
|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 3.04% | 7.8M | 2.7B |
| Vanguard 500 Index Fund | 2.31% | 5.93M | 2.05B |
| Growth Fund Of America Inc | 1.99% | 5.12M | 1.77B |
| Invesco ETF Tr-Invesco QQQ Tr, Series 1 ETF | 1.31% | 3.38M | 1.17B |
| Fidelity Contrafund Inc | 1.27% | 3.26M | 1.13B |
| Vanguard Specialized-Health Care Fund | 1.24% | 3.18M | 1.1B |
| Fidelity 500 Index Fund | 1.09% | 2.81M | 973.81M |
| SPDR S&P 500 ETF Trust | 1.08% | 2.78M | 963.23M |
| New Perspective Fund Inc | 1.03% | 2.64M | 914.72M |
| American Balanced Fund | 0.89% | 2.3M | 795.94M |
CRISPR Therapeutics Has Major Catalysts Ahead. Is This Biotech Stock a Screaming Buy?
04/21 01:30 pm
The Motley Fool
Read moreIs Vertex Pharmaceuticals' Empire in Trouble?
04/16 03:26 pm
The Motley Fool
Read moreBiotechs Racing to Translate Longevity Science Into Real Therapies -- And One Microcap Company Is Producing An Anti-Aging Protein From Genetically Modified, Encapsulated Cells
04/10 09:55 am
Benzinga
Read moreGlobal DNA Read, Write and Edit Market to Surge to $67.7 Billion by 2030, Driven by CRISPR Advances, Genomic Diagnostics and Expanding Clinical Applications
04/07 01:44 pm
GlobeNewswire Inc.
Read moreIdiopathic Membranous Nephropathy Market is Predicted to Reach USD 1 Billion by 2036 Due to Rising Therapeutic Options | DelveInsight
04/06 01:00 pm
GlobeNewswire Inc.
Read moreWhere Will Vertex Pharmaceuticals Be in 1 Year?
03/25 04:02 pm
The Motley Fool
Read moreAnti-Aging Protein Research Takes a Step Forward with Cell Cloning
03/24 11:05 am
Benzinga
Read moreCRISPR Therapeutics Stock: Is It a Bargain Buy Right Now?
03/23 01:30 pm
The Motley Fool
Read moreMy Top 3 Drug Stocks for March 2026
03/20 06:30 am
The Motley Fool
Read moreBest Growth Stock to Buy Right Now: Eli Lilly vs. Vertex Pharmaceuticals
03/19 02:30 pm
The Motley Fool
Read moreUNCF NEW ENGLAND Raises Record-Breaking $800,000 for HBCUs and Student Success
03/19 07:00 am
GlobeNewswire Inc.
Read moreIs Vertex Pharmaceuticals Heading to $600?
03/15 09:15 pm
The Motley Fool
Read moreOil Crashes 10%, Stocks Rebound On Trump End-Of-War Signals: What's Moving Markets Tuesday?
03/10 01:03 pm
Benzinga
Read moreVertex's New Kidney Drug Delivers Big Trial Win, Stock Jumps
03/10 09:24 am
Benzinga
Read more2 Biotech Giants to Buy in 2026
03/05 09:15 am
The Motley Fool
Read moreForget CRISPR Therapeutics: This Gene‑Editing Player Already Boasts the Profits It Dreams Of
03/04 02:23 pm
The Motley Fool
Read moreAbsci Strengthens Clinical Leadership with Appointment of Ransi Somaratne, M.D., FACC, MBA as Chief Medical Officer
03/03 09:00 am
GlobeNewswire Inc.
Read more2 Top Healthcare Stocks to Buy in February
02/26 03:15 pm
The Motley Fool
Read moreForget Centessa Pharmaceuticals: This Rare‑Disease Specialist Has a Superior Portfolio and Pipeline
02/26 02:30 pm
The Motley Fool
Read moreThe Ultimate Biotech Stock to Buy With $500 Right Now
02/24 04:30 am
The Motley Fool
Read moreCould Vertex Stock Help Turn $100,000 Into $1 Million by 2036?
02/22 07:30 pm
The Motley Fool
Read moreCRISPR Therapeutics Gains After Earnings as Pipeline Hope Grows
02/20 11:22 am
Investing.com
Read moreThe Blastoff-Ready Biotech Stock You'll Kick Yourself for Not Buying in 2026
02/13 04:10 pm
The Motley Fool
Read moreSmall Caps, Silver Rally As Inflation Cools Further: What's Moving Markets Friday?
02/13 02:48 pm
Benzinga
Read moreCRISPR Therapeutics Spotlights Momentum For Lead Gene Therapy As Adoption Widens
02/13 02:45 pm
Benzinga
Read more1 Reason I'd Buy Vertex Pharmaceuticals Stock and Never Sell
02/10 02:15 pm
The Motley Fool
Read moreShould You Buy Vertex Before Feb. 12?
02/10 10:35 am
The Motley Fool
Read moreTargeted Cancer Therapy Market to Reach US$ 175.48 Billion by 2035 Driven by Precision Oncology Adoption, ADC Innovation, and Regulatory Productivity Says Astute Analytica
02/03 02:56 am
GlobeNewswire Inc.
Read moreAutologous Cell Therapy Market Size to Reach US$ 44.55 Billion by 2033 | Astute Analytica
01/27 02:43 pm
GlobeNewswire Inc.
Read moreBreaking Barriers: How 2026’s Top Clinical Leaders Are Disrupting Chronic Disease Markets
01/23 01:56 pm
GlobeNewswire Inc.
Read moreStock Market Today, Jan. 15: ImmunityBio Surges After Anktiva Revenue Jumps 700%
01/15 06:27 pm
The Motley Fool
Read morePrediction: These Could Be the Best-Performing Healthcare Stocks Through 2030
01/14 12:15 pm
The Motley Fool
Read morePrediction: 2 Healthcare Stocks That Will Be Worth More Than Pfizer by the End of 2026
01/09 10:30 am
The Motley Fool
Read moreEntrada Therapeutics Highlights Progress Across its Portfolio of RNA-based Therapeutics for the Treatment of Neuromuscular and Ocular Diseases
01/08 08:00 am
GlobeNewswire Inc.
Read moreMy 10 Top Stocks to Buy to Start the New Year Off Right
01/05 09:15 pm
The Motley Fool
Read moreGene Therapy: 5 Biotech Stocks Chasing the $36B Prize
01/02 02:29 pm
Benzinga
Read more3 Supercharged Growth Stocks to Buy and Hold Into the 2030s
12/28 02:13 pm
The Motley Fool
Read moreIs CRISPR Therapeutics Stock Yesterday's News?
12/24 05:15 am
The Motley Fool
Read more12 Days of Investing: My Top 12 Stocks to Buy Before 2026
12/15 12:10 pm
The Motley Fool
Read more2 Stocks That Could Soar by 52% and 282%, According to Wall Street
12/07 10:25 am
The Motley Fool
Read moreDown 10%, Should You Buy the Dip on Vertex Pharmaceuticals?
12/06 08:15 pm
The Motley Fool
Read more1 Reason I'll Never Sell Vertex Pharmaceuticals Stock
12/04 04:10 pm
The Motley Fool
Read moreSickle Cell Disease Market is Predicted to Exhibit Remarkable Growth at a CAGR of 22.1% During the Forecast Period (2025–2034) Across 6MM, Owing to the Increasing Prevalence, Awareness, and Advancements in Gene Therapies | DelveInsight
12/03 02:00 pm
GlobeNewswire Inc.
Read more2 Brilliant Growth Stocks to Buy Now and Hold for the Long Term
12/03 07:15 am
The Motley Fool
Read moreMeet the Beaten-Down Biotech Stock Cathie Wood Loves That Wall Street Says May Soar 50%
11/30 05:10 am
The Motley Fool
Read moreWhere Will Vertex Pharmaceuticals Be in 5 Years
11/27 07:31 am
The Motley Fool
Read more2 Healthcare Stocks For Beginner Investors With a 30-Year Time Horizon
11/23 11:28 am
The Motley Fool
Read more1 Incredible Reason to Buy Vertex Pharmaceuticals Stock in November
11/17 08:15 am
The Motley Fool
Read moreMy 3 Favorite Stocks to Buy Right Now
11/16 10:30 am
The Motley Fool
Read moreNeuer Europachef bei Vertex treibt Produktinnovationen voran und stärkt Lösungen für Compliance
10/30 04:00 am
GlobeNewswire Inc.
Read more